Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3

Weifeng Liu, Udupi Ramagopal, Huiyong Cheng, Jeffrey B. Bonanno, Rafael Toro, Rahul Bhosle, Chenyang Zhan, Steven C. Almo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The apoptotic effect of FasL:Fas signaling is disrupted by DcR3, a unique secreted member of the tumor necrosis factor receptor superfamily, which also binds and neutralizes TL1A and LIGHT. DcR3 is highly elevated in patients with various tumors and contributes to mechanisms by which tumor cells to evade host immune surveillance. Here we report the crystal structure of FasL in complex with DcR3. Comparison of FasL:DcR3 structure with our earlier TL1A:DcR3 and LIGHT:DcR3 structures supports a paradigm involving the recognition of invariant main-chain and conserved side-chain functionalities, which is responsible for the recognition of multiple TNF ligands exhibited by DcR3. The FasL:DcR3 structure also provides insight into the FasL:Fas recognition surface. We demonstrate that the ability of recombinant FasL to induce Jurkat cell apoptosis is significantly enhanced by native glycosylation or by structure-inspired mutations, both of which result in reduced tendency to aggregate. All of these activities are efficiently inhibited by recombinant DcR3.

Original languageEnglish (US)
Pages (from-to)2016-2023
Number of pages8
JournalStructure
Volume24
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Receptors, Tumor Necrosis Factor, Member 6b
Light
Jurkat Cells
Tumor Necrosis Factor Receptors
Glycosylation
Neoplasms
Apoptosis
Ligands
Mutation

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology

Cite this

Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3. / Liu, Weifeng; Ramagopal, Udupi; Cheng, Huiyong; Bonanno, Jeffrey B.; Toro, Rafael; Bhosle, Rahul; Zhan, Chenyang; Almo, Steven C.

In: Structure, Vol. 24, No. 11, 01.11.2016, p. 2016-2023.

Research output: Contribution to journalArticle

Liu, W, Ramagopal, U, Cheng, H, Bonanno, JB, Toro, R, Bhosle, R, Zhan, C & Almo, SC 2016, 'Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3', Structure, vol. 24, no. 11, pp. 2016-2023. https://doi.org/10.1016/j.str.2016.09.009
Liu, Weifeng ; Ramagopal, Udupi ; Cheng, Huiyong ; Bonanno, Jeffrey B. ; Toro, Rafael ; Bhosle, Rahul ; Zhan, Chenyang ; Almo, Steven C. / Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3. In: Structure. 2016 ; Vol. 24, No. 11. pp. 2016-2023.
@article{b4552e160d3f49bca8ad08409be6f00b,
title = "Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3",
abstract = "The apoptotic effect of FasL:Fas signaling is disrupted by DcR3, a unique secreted member of the tumor necrosis factor receptor superfamily, which also binds and neutralizes TL1A and LIGHT. DcR3 is highly elevated in patients with various tumors and contributes to mechanisms by which tumor cells to evade host immune surveillance. Here we report the crystal structure of FasL in complex with DcR3. Comparison of FasL:DcR3 structure with our earlier TL1A:DcR3 and LIGHT:DcR3 structures supports a paradigm involving the recognition of invariant main-chain and conserved side-chain functionalities, which is responsible for the recognition of multiple TNF ligands exhibited by DcR3. The FasL:DcR3 structure also provides insight into the FasL:Fas recognition surface. We demonstrate that the ability of recombinant FasL to induce Jurkat cell apoptosis is significantly enhanced by native glycosylation or by structure-inspired mutations, both of which result in reduced tendency to aggregate. All of these activities are efficiently inhibited by recombinant DcR3.",
author = "Weifeng Liu and Udupi Ramagopal and Huiyong Cheng and Bonanno, {Jeffrey B.} and Rafael Toro and Rahul Bhosle and Chenyang Zhan and Almo, {Steven C.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.str.2016.09.009",
language = "English (US)",
volume = "24",
pages = "2016--2023",
journal = "Structure with Folding & design",
issn = "0969-2126",
publisher = "Cell Press",
number = "11",

}

TY - JOUR

T1 - Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3

AU - Liu, Weifeng

AU - Ramagopal, Udupi

AU - Cheng, Huiyong

AU - Bonanno, Jeffrey B.

AU - Toro, Rafael

AU - Bhosle, Rahul

AU - Zhan, Chenyang

AU - Almo, Steven C.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The apoptotic effect of FasL:Fas signaling is disrupted by DcR3, a unique secreted member of the tumor necrosis factor receptor superfamily, which also binds and neutralizes TL1A and LIGHT. DcR3 is highly elevated in patients with various tumors and contributes to mechanisms by which tumor cells to evade host immune surveillance. Here we report the crystal structure of FasL in complex with DcR3. Comparison of FasL:DcR3 structure with our earlier TL1A:DcR3 and LIGHT:DcR3 structures supports a paradigm involving the recognition of invariant main-chain and conserved side-chain functionalities, which is responsible for the recognition of multiple TNF ligands exhibited by DcR3. The FasL:DcR3 structure also provides insight into the FasL:Fas recognition surface. We demonstrate that the ability of recombinant FasL to induce Jurkat cell apoptosis is significantly enhanced by native glycosylation or by structure-inspired mutations, both of which result in reduced tendency to aggregate. All of these activities are efficiently inhibited by recombinant DcR3.

AB - The apoptotic effect of FasL:Fas signaling is disrupted by DcR3, a unique secreted member of the tumor necrosis factor receptor superfamily, which also binds and neutralizes TL1A and LIGHT. DcR3 is highly elevated in patients with various tumors and contributes to mechanisms by which tumor cells to evade host immune surveillance. Here we report the crystal structure of FasL in complex with DcR3. Comparison of FasL:DcR3 structure with our earlier TL1A:DcR3 and LIGHT:DcR3 structures supports a paradigm involving the recognition of invariant main-chain and conserved side-chain functionalities, which is responsible for the recognition of multiple TNF ligands exhibited by DcR3. The FasL:DcR3 structure also provides insight into the FasL:Fas recognition surface. We demonstrate that the ability of recombinant FasL to induce Jurkat cell apoptosis is significantly enhanced by native glycosylation or by structure-inspired mutations, both of which result in reduced tendency to aggregate. All of these activities are efficiently inhibited by recombinant DcR3.

UR - http://www.scopus.com/inward/record.url?scp=84993977943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993977943&partnerID=8YFLogxK

U2 - 10.1016/j.str.2016.09.009

DO - 10.1016/j.str.2016.09.009

M3 - Article

C2 - 27806260

AN - SCOPUS:84993977943

VL - 24

SP - 2016

EP - 2023

JO - Structure with Folding & design

JF - Structure with Folding & design

SN - 0969-2126

IS - 11

ER -